Reply to “Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection: novel concerns”
We appreciate the letter from Dr. Sha and colleagues in response to our recent report on antiviral therapy (AVT) in patients with HBV-related intrahepatic cholangiocarcinoma (ICC) undergoing partial hepatectomy.[1] We would like to thank the readers for their interest in our study.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Jun Li, Zhengqing Lei, Kui Wang, Feng Shen Tags: Letter to the Editor Source Type: research
More News: Antiviral Therapy | Bile Duct Cancer | Cholangiocarcinoma | Gastroenterology | Liver | Study | Urology & Nephrology